Carlyle Group INC Form 4 insider transactions

Carlyle Group and related entities have reported the sale of 8,260,183 shares of QuidelOrtho Corp at a price of $35.314 per share.

Carlyle Group director Daniel A. D'Aniello sold 495,542 shares of common stock in multiple transactions as part of estate planning.

Carlyle Group Inc. reports the sale of 250,000 shares of Complete Solaria, Inc. at an average price of $2.329 per share.

Carlyle Group continues to reduce its stake in Complete Solaria, Inc. through a series of transactions executed under a pre-arranged Rule 10b5-1 plan.

Carlyle Group Inc. reports the sale of Complete Solaria (CSLR) shares on October 11 and 14, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Carlyle Group continues to reduce its stake in Complete Solaria through sales executed under a pre-arranged Rule 10b5-1 trading plan.

Carlyle Group, a major shareholder of Complete Solaria, Inc. (CSLR), has sold a portion of its holdings in two transactions on October 7 and 8, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Carlyle Group Inc. reports the sale of 12,849,448 shares of StandardAero, Inc. common stock at a price of $22.74 per share on October 3, 2024.

Carlyle Group and related entities report receiving shares of CommScope Holding Company Series A Convertible Preferred Stock as a payment-in-kind dividend.

Chief Operating Officer Lindsay LoBue reports the acquisition of dividend equivalent units related to existing restricted stock unit awards.

Carlyle Group's CFO, John C. Redett, acquired 3,887 shares of common stock through dividend equivalent units, increasing his total holdings to 984,696 shares.

Harvey Schwartz, CEO of Carlyle Group Inc., acquired 49,508 shares of common stock on August 26, 2024, through dividend equivalent units.

Charles E. Andrews, Jr., Chief Accounting Officer of Carlyle Group Inc., reports the acquisition of dividend equivalent units related to existing restricted stock unit awards.

Jeffrey W. Ferguson, General Counsel of Carlyle Group Inc., reports the acquisition of 1,007 shares of common stock through dividend equivalent units.

Carlyle Group executed sales of QuidelOrtho Corp (QDEL) common stock on August 9, 2024, under a pre-arranged Rule 10b5-1 trading plan.

The Carlyle Group executed multiple sales of QuidelOrtho Corp (QDEL) common stock between August 7th and August 8th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Carlyle Group exercised warrants to purchase Complete Solaria (CSLR) common stock at $0.01 per share, resulting in the acquisition of 4,901,340 shares after withholding for exercise price.

Carlyle Group Inc. reports the sale of QuidelOrtho Corp shares across multiple transactions on August 5th and 6th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Carlyle Group Inc. reports the sale of QuidelOrtho Corp shares across multiple transactions on August 1st and 2nd, 2024, executed under a pre-arranged Rule 10b5-1 trading plan.

Charles Elliott Andrews Jr., Chief Accounting Officer of Carlyle Group Inc., reports the withholding of common stock shares for tax obligations related to vesting restricted stock units.

Jeffrey W. Ferguson, General Counsel of Carlyle Group Inc., reports the withholding of shares for tax obligations related to vesting restricted stock units.

The Carlyle Group executed multiple sales of QuidelOrtho Corp shares on July 30 and 31, 2024, under a pre-arranged Rule 10b5-1 trading plan.

The Carlyle Group Inc. reports the sale of QuidelOrtho Corp shares across multiple transactions executed between July 26 and July 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Carlyle Group Inc. reports the sale of QuidelOrtho Corp shares across multiple transactions on July 24 and 25, 2024, executed under a pre-arranged Rule 10b5-1 trading plan.

The Carlyle Group executed multiple sales of QuidelOrtho Corp shares between July 22 and July 23, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Carlyle Group executed multiple sales of QuidelOrtho Corp (QDEL) common stock on July 18 and 19, 2024, under a pre-arranged Rule 10b5-1 trading plan.

The Carlyle Group continues to reduce its stake in QuidelOrtho Corp, selling shares through a pre-arranged trading plan.

Carlyle Group continues to reduce its stake in QuidelOrtho Corp through a series of sales executed under a pre-arranged Rule 10b5-1 trading plan.

Carlyle Group Management L.L.C. filed a Form 4 disclosing a transfer of 17,000 common shares to the existing indirect beneficial owner on July 10, 2024.

Carlyle Group Inc. sold shares of QuidelOrtho Corp (QDEL) between July 10 and July 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.